Pulsenmore Ltd.
No enriched coverage for $PLSM in the last 7 days.
No SEC Form 4 filings for $PLSM in the last 30 days.
Pulsenmore Ltd. (NASDAQ:PLSM) shares jumped about 160% after the company said it was selected for Israel’s Healthcare AI Regulatory Sandbox Program by the Israel Innovation Authority and Ministry of Health. Pulsenmore will receive funding for a $1 million project to develop and clinically validate AI for its home ultrasound platform, with Beilinson Hospital/Clalit Health Services.
Selection into a regulated AI sandbox with dedicated funding is a near-term positive catalyst, but scale is modest and execution risk remains.
alphai scores every news story that mentions PLSM with an AI model for sentiment and relevance, and aggregates insider trades from Pulsenmore Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Pulsenmore Ltd. (NASDAQ:PLSM) shares jumped about 160% after the company said it was selected for Israel’s Healthcare AI Regulatory Sandbox Program by the Israel Innovation Authority and Ministry of Health. Pulsenmore will receive funding for a $1 million project to develop and clinically validate AI for its home ultrasound platform, with Beilinson Hospital/Clalit Health Services.
3 min read